TTD | Drug: D04UCF

Drug General Information
Drug ID	D04UCF
Former ID	DIB020400
Drug Name	MRE 3010F20
Synonyms	MRE-3010F20
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[467889]
Structure		Download 2D MOL
Formula	C21H22ClN7O2
InChI	InChI=1S/C21H22ClN7O2/c1-2-8-29-11-14-16-17(25-19(24-16)15-7-4-9-31-15)20(26-18(14)28-29)27-21(30)23-13-6-3-5-12(22)10-13/h3,5-6,10-11,15,17H,2,4,7-9H2,1H3,(H2,23,26,27,28,30)
InChIKey	AQJYVSDITBKWSI-UHFFFAOYSA-N
PubChem Compound ID	73754994
PubChem Substance ID	135650632
Target and Pathway
Target(s)	Adenosine A3 receptor	Target Info	Antagonist	[525758]
Reactome	Adenosine P1 receptors
Reactome	G alpha (i) signalling events
WikiPathways	Nucleotide GPCRs
	GPCRs, Class A Rhodopsin-like
	GPCRs, Other
References
Ref 467889	(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 465).
Ref 525758	[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. Mol Pharmacol. 2000 May;57(5):968-75.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information